Differential growth inhibition of cerebral metastases by anti-angiogenic compounds - Wikidata - wikimedia - TriplyDB

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

http://www.wikidata.org/entity/Q35304863

about

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

http://www.wikidata.org/entity/Q35304863

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

@ast

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

@en

type

label

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

@ast

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

@en

prefLabel

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

@ast

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

@en

P1433

Q35304863-6FCC7F53-BABD-4333-9F06-F9F1FFD71F24

P1476

Q35304863-4B079578-8E4B-43E7-AD76-C4186EE81F78

P2093

Q35304863-20C308AB-8A3F-461E-8193-C1E4D496F6E1

Q35304863-3C91433B-5659-4FC8-9660-EE79C44DF5AB

Q35304863-3D838B7D-F5F7-4CEC-B30A-7BDC76A5F87C

Q35304863-8DFA58AE-6735-4058-8D51-95EED5CCA730

Q35304863-A0D6F50C-4DD2-4256-A579-4697C24DD2B1

Q35304863-AD848BD1-81B7-4EFA-9073-E394AED31077

Q35304863-AD8E2E80-5704-4AE9-B96E-2DBB9E689694

Q35304863-BB2D6FC8-AC73-4D9C-BB9B-B5ECBEA993A0

Q35304863-CBDD0E55-572A-41AE-9369-EA30376D7338

P2860

Q35304863-02D57FDE-4C5C-4578-B044-2E0E9E8DECE0

Q35304863-082519A3-2DF5-4A82-AB1C-A5492D1363F6

Q35304863-0BE50D84-9CF7-4BCB-B633-DD73E65A5B31

Q35304863-0E1AB96C-8DF1-44AE-A57A-7236ACCC3D89

Q35304863-0EC46425-83D9-4DBB-925A-D9E7C086E88E

Q35304863-1E99AFBA-E12B-4812-8F40-63C2530033F5

Q35304863-2D0D3D03-E54A-4287-8895-15826D1B3B92

Q35304863-302BD992-EE25-49AF-AE73-C54645644488

Q35304863-32C24FD0-03C8-4795-9928-178B863A456B

Q35304863-396B5A61-B20A-4D50-8B46-D6D50920C872

P304

Q35304863-22826E0B-3A6E-4957-B01B-7EF546F2C95E

P31

Q35304863-5532933C-5111-4DB6-AB24-5EEA4008D0DF

P407

Q35304863-E60F9BDD-DFC4-413B-8BCA-3758251D2B3D

P433

Q35304863-6860CA5F-8592-40D9-A397-C8EB52310007

P478

Q35304863-2817B056-CEF3-47C6-A7B5-E7F5B27170B7

P50

Q35304863-4167C2AB-24F0-49EA-BB71-FAA52B9D0ED9

P577

Q35304863-22649C57-B6C8-4A87-A8D0-EA7C6A251D63

P698

Q35304863-74853747-B610-49E1-8C2D-479C5FF86C84

P932

Q35304863-20A2AD88-D0E2-4E73-9958-9C1B0E0B242C

P1433

Anticancer Research

P1476

Differential growth inhibition of cerebral metastases by anti-angiogenic compounds

@en

P2093

Aiko Bertram

http://www.w3.org/2001/XMLSchema#string

Corina Liebner

http://www.w3.org/2001/XMLSchema#string

Daniel K Martin

http://www.w3.org/2001/XMLSchema#string

Edith M Lord

http://www.w3.org/2001/XMLSchema#string

Gabriele Schackert

http://www.w3.org/2001/XMLSchema#string

Kerim Hakan Sitoci-Ficici

http://www.w3.org/2001/XMLSchema#string

Matthias Kirsch

http://www.w3.org/2001/XMLSchema#string

Ortrud Uckermann

http://www.w3.org/2001/XMLSchema#string

Sandy Hendruschk

http://www.w3.org/2001/XMLSchema#string

P2860

Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway

Integrins in cancer: biological implications and therapeutic opportunities

Tumorigenesis and the angiogenic switch

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.

Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group.

Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.

Hypoxia: the tumor's gateway to progression along the angiogenic pathway.

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

P304

3293-3302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24982333

http://www.w3.org/2001/XMLSchema#string

P932

4388740

http://www.w3.org/2001/XMLSchema#string